BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.510
-0.090 (-5.63%)
At close: Mar 20, 2026, 4:00 PM EDT
1.539
+0.029 (1.95%)
After-hours: Mar 20, 2026, 7:49 PM EDT

BioXcel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3319886055691,128
Market Cap Growth
352.37%-78.99%-85.40%6.29%-49.57%326.88%
Enterprise Value
106.1391.27124.11504.71336.97916.34
Last Close Price
1.515.9847.20343.68325.28739.20
PE Ratio
--0.25-0.48-3.63-5.02-12.19
PS Ratio
43.918.1963.981612.26--
PB Ratio
--0.20-1.567.872.575.46
P/TBV Ratio
-0.13-0.16-1.527.842.424.85
P/FCF Ratio
--0.26-0.57-4.46-6.89-16.92
P/OCF Ratio
--0.26-0.57-4.47-6.92-17.00
EV/Sales Ratio
141.1340.2889.941345.89--
EV/EBITDA Ratio
--1.36-0.72-3.17-3.16-11.16
EV/EBIT Ratio
--1.36-0.72-3.16-3.15-11.13
EV/FCF Ratio
--1.27-0.80-3.73-4.08-13.75
Debt / Equity Ratio
-1.04-1.10-1.791.220.000.01
Debt / EBITDA Ratio
-2.17-1.53-0.59-0.59-0.01-0.02
Debt / FCF Ratio
-1.87-1.42-0.65-0.69-0.01-0.02
Net Debt / Equity Ratio
-0.81-0.78-0.63-1.30-1.05-1.02
Net Debt / EBITDA Ratio
-1.43-1.09-0.210.632.172.58
Net Debt / FCF Ratio
-1.23-1.01-0.230.742.813.18
Asset Turnover
0.020.040.010.0000
Inventory Turnover
1.721.610.630.02--
Quick Ratio
0.991.352.395.9013.9818.00
Current Ratio
1.171.682.656.1714.2118.33
Return on Equity (ROE)
74.95%79.67%-1766.94%-111.08%-49.93%-70.57%
Return on Assets (ROA)
-121.91%-120.04%-122.90%-71.70%-46.56%-64.21%
Return on Invested Capital (ROIC)
383.37%425.59%897.57%1077.12%1492.46%1883.66%
Return on Capital Employed (ROCE)
-438.85%-215.05%-156.60%-80.68%-49.64%-69.74%
Earnings Yield
-206.56%-393.14%-208.33%-27.56%-19.92%-8.20%
FCF Yield
-176.28%-388.29%-175.58%-22.41%-14.52%-5.91%
Buyback Yield / Dilution
-116.00%-213.95%-31.19%-0.05%-18.01%-21.93%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q